{"id":561271,"date":"2026-07-25T12:30:00","date_gmt":"2026-07-25T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=561271"},"modified":"2026-07-25T12:40:13","modified_gmt":"2026-07-25T10:40:13","slug":"mutations-and-molecular-diagnostics-in-treatment-decisions","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/mutations-and-molecular-diagnostics-in-treatment-decisions\/","title":{"rendered":"Mutations and Molecular Diagnostics in Treatment Decisions"},"content":{"rendered":"\n

Primary myelofibrosis (PMF) is a rare, biologically complex myeloproliferative neoplasm whose course is strongly influenced by molecular, epigenetic, and immunological factors. Advances in genomics, spatial transcriptomics, and targeted therapies have fundamentally transformed diagnosis and treatment in recent years and are increasingly enabling more precise, personalized treatment decisions. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Primary myelofibrosis (PMF) is a rare, biologically complex myeloproliferative neoplasm whose course is strongly influenced by molecular, epigenetic, and immunological factors. Advances in genomics, spatial transcriptomics, and targeted therapies have……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":561286,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Myelofibrosis ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11508,11353,11370,11503],"tags":[97385,97319,97361,97309,97328,97294,97313,97305,97426,97345,97370,97311,92527,97400,97365,97303,97322,97376,97326,97307,97389,92519,97333,97324,97420,97436,97349,65704,97318,97296,97374,97380,97403,97316,97293,97409,97299,97336,97446,97440,97320,97358,97330,97430,97418,97290,97354,97392,97434,97337,97301,97314,97396,97340,73704,97413],"powerkit_post_featured":[],"class_list":["post-561271","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-education","category-hematology","category-oncology","category-studies","tag-acvr1-inhibition","tag-aml-transformation","tag-anemia-specific-treatment","tag-asxl1-mutation","tag-bone-marrow-niche","tag-calr-mutation","tag-chip-clones","tag-clonal-evolution","tag-combination-therapies-for-myelofibrosis","tag-cytokine-driven-clonal-expansion","tag-danazol","tag-dann-methylation","tag-epigenetic-dysregulation","tag-epigenetic-modulators","tag-erythropoiesis-stimulating-agents-2","tag-ezh2-mutation","tag-gipss","tag-hepcidin-modulation","tag-high-risk-mutations","tag-idh1-idh2-mutation","tag-imetelstat","tag-immune-microenvironment","tag-inflammation-in-mpn","tag-inflammatory-cytokines","tag-inflammatory-signaling-pathway-inhibitors","tag-innovative-treatments-for-myelofibrosis","tag-jak-inhibitor-resistance","tag-jak-stat-pathway","tag-jak2-allele-load","tag-jak2v617f","tag-luspatercept","tag-metabolic-interventions","tag-metabolic-target-structures","tag-mipss70","tag-mitotic-defects-in-calr","tag-molecular-markers-for-myelofibrosis","tag-mpl-mutation","tag-mpn-microenvironment","tag-mpn-registry-switzerland","tag-myelofibrosis-care-in-switzerland","tag-mysec-pm","tag-new-treatments-for-myelofibrosis","tag-nf-b-signaling-pathway","tag-ngs-diagnostics-for-myelofibrosis","tag-personalized-therapy-for-myelofibrosis","tag-primary-myelofibrosis","tag-ruxolitinib-biomarkers","tag-ruxolitinib-combination-therapy","tag-spatial-transcriptomics","tag-spatial-tumor-biology","tag-srsf2-mutation","tag-subclonal-mutations","tag-telomerase-inhibition","tag-tgf--mediated-fibrosis","tag-transfusions","tag-treatment-resistant-myelofibrosis","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-05 20:29:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":561272,"slug":"mutations-et-diagnostic-moleculaire-dans-le-choix-du-traitement","post_title":"Mutations et diagnostic mol\u00e9culaire dans le choix du traitement","href":"https:\/\/medizinonline.com\/fr\/mutations-et-diagnostic-moleculaire-dans-le-choix-du-traitement\/"},"it_IT":{"locale":"it_IT","id":561297,"slug":"mutazioni-e-diagnostica-molecolare-nel-processo-decisionale-terapeutico","post_title":"Mutazioni e diagnostica molecolare nel processo decisionale terapeutico","href":"https:\/\/medizinonline.com\/it\/mutazioni-e-diagnostica-molecolare-nel-processo-decisionale-terapeutico\/"},"pt_PT":{"locale":"pt_PT","id":561301,"slug":"mutacoes-e-diagnostico-molecular-na-decisao-terapeutica","post_title":"Muta\u00e7\u00f5es e diagn\u00f3stico molecular na decis\u00e3o terap\u00eautica","href":"https:\/\/medizinonline.com\/pt-pt\/mutacoes-e-diagnostico-molecular-na-decisao-terapeutica\/"},"es_ES":{"locale":"es_ES","id":561306,"slug":"mutaciones-y-diagnostico-molecular-en-la-toma-de-decisiones-terapeuticas","post_title":"Mutaciones y diagn\u00f3stico molecular en la toma de decisiones terap\u00e9uticas","href":"https:\/\/medizinonline.com\/es\/mutaciones-y-diagnostico-molecular-en-la-toma-de-decisiones-terapeuticas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=561271"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561271\/revisions"}],"predecessor-version":[{"id":561289,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561271\/revisions\/561289"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/561286"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=561271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=561271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=561271"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=561271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}